Global practice patterns and outcomes for metastatic uveal melanoma treated regionally versus systemically. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I. This abstract does not ...
Nicox SA has entered into an exclusive research and license option agreement with Glaukos Corp. for NCX-1728, Nicox’s novel nitric oxide (NO)-donating phosphodiesterase PDE5 inhibitor. NCX-1728 is the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results